We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 49

A Look Inside Trump's 4-Point Plan For Curbing Drug Prices
  • Ropes & Gray LLP
  • USA
  • May 18 2018

On May 11, President Donald Trump outlined his administration’s four-point plan for curbing prescription drug prices. With rare exceptions, the plan


Health Care Provisions in Bipartisan Budget Act of 2018
  • Ropes & Gray LLP
  • USA
  • February 23 2018

On Friday, February 9, President Trump signed The Bipartisan Budget Act of 2018 (the “2018 Act”) into law. Among other things, the 2018 Act makes


Agency Guidance Limits May Shift Health Care Enforcement
  • Ropes & Gray LLP
  • USA
  • February 12 2018

On Jan. 25, 2018, the U.S. associate attorney general issued a memorandum directing civil litigators in the U.S. Department of Justice to limit


DOJ Enforcement Memorandum Signals Policy Shift in Deference to Agency Guidance Documents for Civil Health Care Enforcement Matters
  • Ropes & Gray LLP
  • USA
  • February 5 2018

On January 25, 2018, the U.S. Associate Attorney General issued a memorandum directing civil litigators in the U.S. Department of Justice ("DOJ") to


Brave New World: Compliance and the Transition to Value-Based Care
  • Ropes & Gray LLP
  • USA
  • May 22 2017

The U.S. health care system is in the midst of a fundamental shift, away from traditional “fee-for-service” models that reward providers for the


Outlook 2017 Teleconference: Revisiting the Trump Administration’s Impact on Life Sciences and Health Carethe First 100 Days
  • Ropes & Gray LLP
  • USA
  • May 2 2017

On Tuesday, May 2, Ropes & Gray hosted a teleconference, “Outlook 2017 Teleconference: Revisiting the Trump Administration’s Impact on Life Sciences


First Circuit Holds That, for Original Source Exception to the False Claims Act's Public Disclosure Bar to Apply, Information Supplied Must Be "Significant" or "Essential"
  • Ropes & Gray LLP
  • USA
  • January 26 2017

On June 30, 2016, the First Circuit addressed the kinds of information that a relator must provide to qualify as an original source to avoid


First Circuit Adopts “Arm of the State” Test to Affirm Dismissal of FCA Complaint
  • Ropes & Gray LLP
  • USA
  • September 9 2016

In January 2016 in a matter of first impression, the First Circuit held that the University of Massachusetts Medical School is a state agency, and


HHS OCR Offers New Materials for Covered Entities to Promote Compliance with the Affordable Care Act’s Nondiscrimination Provisions Now in Effect
  • Ropes & Gray LLP
  • USA
  • September 1 2016

Hospitals, health clinics, health insurance issuers, State Medicaid agencies, community health centers, physician practices, home health care


CMS Issues Final Rule on Overhaul of Clinical Diagnostic Laboratory Test Payment System
  • Ropes & Gray LLP
  • USA
  • July 26 2016

On June 17, 2016, the Centers for Medicare & Medicaid Services (“CMS”) issued a final rule (the “Final Rule”) that makes significant changes to